| Literature DB >> 23538073 |
David Mischoulon1, Marlene P Freeman.
Abstract
Over the past 2 decades, omega-3 fatty acids (n-3FAs) have been increasingly used and studied in the United States and worldwide for various medical and psychiatric indications. Numerous published clinical trials have examined applications of different n-3FA preparations, primarily in mood disorders but also in psychotic disorders, attention-deficit disorder, obsessive-compulsive disorder, and personality disorders. Focusing on clinical issues, this article reviews the impact of n-3FAs on these conditions and covers the relevant research, side effects, dosage guidelines, and drug interactions; clinicians should thus be able to better advise patients who are already taking n-3FAs or are interested in trying them.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23538073 DOI: 10.1016/j.psc.2012.12.002
Source DB: PubMed Journal: Psychiatr Clin North Am ISSN: 0193-953X